Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
2010
8
Last FY Revenue $0.3M
Last FY EBITDA -$1.8M
$4.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Simris Alg achieved revenue of $0.3M and an EBITDA of -$1.8M.
Simris Alg expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Simris Alg valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $0.3M | XXX | XXX | XXX |
Gross Profit | XXX | $0.1M | XXX | XXX | XXX |
Gross Margin | XXX | 42% | XXX | XXX | XXX |
EBITDA | XXX | -$1.8M | XXX | XXX | XXX |
EBITDA Margin | XXX | -607% | XXX | XXX | XXX |
EBIT | XXX | -$3.6M | XXX | XXX | XXX |
EBIT Margin | XXX | -1201% | XXX | XXX | XXX |
Net Profit | XXX | -$3.6M | XXX | XXX | XXX |
Net Margin | XXX | -1197% | XXX | XXX | XXX |
Net Debt | XXX | $10K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Simris Alg's stock price is SEK 0 (or $0).
Simris Alg has current market cap of SEK 40.3M (or $4.2M), and EV of SEK 40.4M (or $4.2M).
See Simris Alg trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$4.2M | $4.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Simris Alg has market cap of $4.2M and EV of $4.2M.
Simris Alg's trades at 14.0x EV/Revenue multiple, and -2.3x EV/EBITDA.
Equity research analysts estimate Simris Alg's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Simris Alg's P/E ratio is not available.
See valuation multiples for Simris Alg and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $4.2M | XXX | $4.2M | XXX | XXX | XXX |
EV (current) | $4.2M | XXX | $4.2M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 14.0x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -2.3x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -1.2x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -1.2x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -2.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSimris Alg's revenue per employee in the last FY averaged $37K, while opex per employee averaged $0.5M for the same period.
Simris Alg's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Simris Alg's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Simris Alg and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -607% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $37K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 1243% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Simris Alg acquired XXX companies to date.
Last acquisition by Simris Alg was XXXXXXXX, XXXXX XXXXX XXXXXX . Simris Alg acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Simris Alg founded? | Simris Alg was founded in 2010. |
Where is Simris Alg headquartered? | Simris Alg is headquartered in Sweden. |
How many employees does Simris Alg have? | As of today, Simris Alg has 8 employees. |
Is Simris Alg publicy listed? | Yes, Simris Alg is a public company listed on STO. |
What is the stock symbol of Simris Alg? | Simris Alg trades under SIMRIS B ticker. |
When did Simris Alg go public? | Simris Alg went public in 2016. |
Who are competitors of Simris Alg? | Similar companies to Simris Alg include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
What is the current market cap of Simris Alg? | Simris Alg's current market cap is $4.2M |
Is Simris Alg profitable? | Yes, Simris Alg is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.